Literature DB >> 3731614

The results and morbidity of varus osteotomy for Perthes' disease.

M R Karpinski, G Newton, A P Henry.   

Abstract

The results of varus proximal femoral osteotomy in 55 hips in 52 patients were analyzed by Harrison's radiologic autoassessment method. Excluding operations upon Catterall Grade 1 hips, 75.6% were either therapeutic successes or unchanged; 24.4% were therapeutic failures. These results are compared with and shown to be similar to those of patients treated conservatively by the Birmingham splint. In ten children with Catterall Grade 1 disease, seven were unchanged but three were therapeutic failures. Improved end results occurred in hips with greater surgical varus than those in which the end result worsened, but the statistical significance was questionable. The bone remodelling in response to surgical varus was unpredictable, but the greater the surgical varus the less the correction of the neck shaft angle at follow-up evaluation. Chronologic age cannot be used to predict such bone remodelling as may be impaired by the disease process. An analysis of the incidence and significance of leg shortening, limping, and abductor lurch is presented and some observations made on trochanteric overgrowth and the effect of surgery on the rate of femoral head reconstitution. New attempts to achieve containment of the hip by high-femoral osteotomy may determine the effects of a combination of varus and selective rotation osteotomy using ultrasound scans to measure femoral torsion before operation.

Entities:  

Mesh:

Year:  1986        PMID: 3731614

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  2 in total

1.  The natural history of Perthes' disease.

Authors:  R Norlin; S Hammerby; H Tkaczuk
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

2.  Can residual leg shortening be predicted in patients with Legg-Calvé-Perthes' disease?

Authors:  Kwang-Won Park; Kyu-Seon Jang; Hae-Ryong Song
Journal:  Clin Orthop Relat Res       Date:  2013-04-25       Impact factor: 4.176

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.